API
< Back to all clusters
[HEALTH] · United States, India, China · 29 sources

started · updated

Alzheimer’s research: New blood tests and drugs show promise

Recent medical research highlights significant advancements in the detection and treatment of Alzheimer’s disease. A study published in JAMA Neurology by the Mayo Clinic suggests that a blood test detecting phosphorylated tau 217 (p-tau217) could predict cognitive decline in older adults within five to ten years. This method is considered less invasive and more scalable than traditional PET scans.

In clinical trials spanning 13 countries, the drug AR1001, a phosphodiesterase-5 inhibitor similar to the mechanism of Viagra, is being tested. Researchers report that the once-a-day tablet may reduce cognitive decline in Alzheimer’s patients by nearly one third by increasing blood flow to the brain.

Additionally, research published in Nature Aging indicates that the brain’s ability to clear metabolic waste through cerebrospinal fluid during sleep may diminish with age. This decline is linked to reduced blood flow responses in older adults, potentially increasing the risk of neurodegenerative diseases.

Entities

AfD · Alamar Biosciences · Alzheimer’s Society · Biogen · Calvary Church · Catholic Church · Essen · Franz-Josef Overbeck · Germany · Harvard Medical School · Institute for Employment Research · Ionis Pharmaceuticals

Claims

What the coverage asserts, and how many sources carry each claim.

  • [○ 1 SOURCE] The chocolate figure features a blue coat, a mitre with a cross, a crosier, and a book with the AfD logo. lokalo.de
  • [○ 1 SOURCE] The AfD defended the design by citing their commitment to Christian values. lokalo.de
  • [○ 1 SOURCE] Bishop Franz-Josef Overbeck accused the AfD of appropriating Christian symbols for political advertising. lokalo.de
  • [○ 1 SOURCE] The chocolate figure was offered for 1.35 Euro per piece. lokalo.de
  • [○ 1 SOURCE] The AfD is offering a chocolate St. Nicholas figure in its official promotional shop. lokalo.de
  • [● 3 SOURCES] Diranersen uses gene-silencing technology to block RNA messages that instruct cells to produce tau.
  • [○ 1 SOURCE] The drug AR1001 is being tested in 13 countries. www.news9live.com
  • [● 3 SOURCES] The diranersen injection slowed cognitive decline by 54 percent in a large study.
  • [● 2 SOURCES] A blood test detecting p-tau217 can predict cognitive decline within five to ten years. www.foxnews.com · www.ithome.com
  • [○ 1 SOURCE] AR1001 can reduce cognitive decline in Alzheimer’s patients by almost a third. www.news9live.com
  • [○ 1 SOURCE] The lowest dose of diranersen slowed cognitive decline by 38 percent after two years. srnnews.com
  • [○ 1 SOURCE] Cerebrospinal fluid flow in the brain may decrease with age due to reduced vascular response to oxygen needs. www.ithome.com

Sources

Wenn Weihnachten wieder so plötzlich ist [www.mortimer-reisemagazin.de]